Ignite Creation Date:
2024-05-06 @ 7:05 PM
Last Modification Date:
2024-10-26 @ 3:00 PM
Study NCT ID:
NCT05888337
Status:
TERMINATED
Last Update Posted:
2023-12-13
First Post:
2023-05-25
Brief Title:
Comparison of Contoura Vision Outcomes Programmed Using the Manifest Refraction Verses Using Phorcides Planning Software in Patients With Oblique Astigmatism
Sponsor:
Bismarck Lasik
Organization:
Bismarck Lasik
Study Overview
Official Title:
Comparison of Contoura Vision Outcomes Programmed Using the Manifest Refraction Verses Using Phorcides Planning Software in Patients With Oblique Astigmatism
Status:
TERMINATED
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Difficult to find recruit patients with oblique astigmatism
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective is to compare the percentage of monocular UDVA -01 logMAR 2016 outcomes for each planning strategy Phorcides and manifest refraction at the 3-month post operative visit
Detailed Description:
This study is a randomized prospective contralateral eye study of visual outcomes in eyes planned with Phorcides compared to eyes planned using the manifest refraction after successful bilateral LASIK surgery Subjects will be assessed pre-operatively operatively and at 3 months postoperatively Clinical evaluations will include measurement of visual acuity manifest refraction and administration of a questionnaire
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None